| Literature DB >> 31822191 |
Rajesh Balasubramanian1, Rachel Rolph2, Catrin Morgan3, Hisham Hamed4.
Abstract
The last two decades have witnessed major advances in genetic sequencing which have led to more accurate identification of women at risk of developing breast cancer and calculating the associated cancer risk. This review discusses the current genetic mutations conferring risk of developing breast cancer and the management pathway for these women with identifiable mutations as well as those with a strong family history for breast cancer. Management of these individuals is complex and should involve a multidisciplinary team with interest and expertise in breast cancer genetics. There are several treatment options ranging from surveillance to risk-reducing surgery. Risk reduction surgery has been popularised by celebrities who are carriers of breast cancer genes, and raised public awareness of breast cancer genetics and associated risk.Entities:
Mesh:
Year: 2019 PMID: 31822191 DOI: 10.12968/hmed.2019.80.12.720
Source DB: PubMed Journal: Br J Hosp Med (Lond) ISSN: 1750-8460 Impact factor: 0.825